I. Havlík

925 total citations
35 papers, 736 citations indexed

About

I. Havlík is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Pharmacology. According to data from OpenAlex, I. Havlík has authored 35 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Public Health, Environmental and Occupational Health, 6 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in I. Havlík's work include Malaria Research and Control (13 papers), Drug Transport and Resistance Mechanisms (4 papers) and Mosquito-borne diseases and control (4 papers). I. Havlík is often cited by papers focused on Malaria Research and Control (13 papers), Drug Transport and Resistance Mechanisms (4 papers) and Mosquito-borne diseases and control (4 papers). I. Havlík collaborates with scholars based in South Africa, United Kingdom and Czechia. I. Havlík's co-authors include Jeffrey Lipman, Paul E. Marik, D.J.H. Veale, David W. Johnson, Peter A. Kraus, Yutaro Kaneko, Robyn L. van Zyl, Douglas W. Oliver, Barry I. Joffe and Vanessa R. Panz and has published in prestigious journals such as CHEST Journal, Antimicrobial Agents and Chemotherapy and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

I. Havlík

35 papers receiving 699 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Havlík South Africa 15 193 172 114 107 93 35 736
Jean-Jacques Dugoua Canada 13 101 0.5× 115 0.7× 122 1.1× 47 0.4× 87 0.9× 17 596
Jill M. Grimes Serrano United States 16 128 0.7× 250 1.5× 91 0.8× 81 0.8× 92 1.0× 24 766
Ananya Chatterjee India 15 92 0.5× 129 0.8× 119 1.0× 101 0.9× 165 1.8× 49 895
B. Diquet France 18 120 0.6× 93 0.5× 43 0.4× 210 2.0× 181 1.9× 62 1.2k
J. K. Faulkner United Kingdom 16 207 1.1× 74 0.4× 46 0.4× 137 1.3× 130 1.4× 32 1.1k
Pingping Jiang Denmark 23 171 0.9× 126 0.7× 55 0.5× 89 0.8× 350 3.8× 79 1.4k
Douglas D. Glover United States 14 106 0.5× 412 2.4× 57 0.5× 65 0.6× 147 1.6× 27 1.1k
Indu Mani United States 13 57 0.3× 57 0.3× 61 0.5× 57 0.5× 191 2.1× 28 754
Kathleen M. Job United States 16 92 0.5× 82 0.5× 98 0.9× 55 0.5× 99 1.1× 31 663
Marc G. Sturgill United States 12 126 0.7× 53 0.3× 39 0.3× 86 0.8× 142 1.5× 32 842

Countries citing papers authored by I. Havlík

Since Specialization
Citations

This map shows the geographic impact of I. Havlík's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Havlík with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Havlík more than expected).

Fields of papers citing papers by I. Havlík

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Havlík. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Havlík. The network helps show where I. Havlík may publish in the future.

Co-authorship network of co-authors of I. Havlík

This figure shows the co-authorship network connecting the top 25 collaborators of I. Havlík. A scholar is included among the top collaborators of I. Havlík based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Havlík. I. Havlík is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davids, Hajierah, et al.. (2010). Endogenous heparin levels in the controlled asthmatic patient. South African Medical Journal. 100(5). 307–307. 6 indexed citations
2.
Havlík, I., S Looareesuwan, Suparp Vannaphan, et al.. (2005). Curdlan sulphate in human severe/cerebral Plasmodium falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 99(5). 333–340. 37 indexed citations
3.
Veale, D.J.H., et al.. (2002). Seasonal variation in uterotonic activity of Rhoicissus tridentata extracts.. PubMed. 92(5). 375–7. 3 indexed citations
4.
Veale, D.J.H., Jan L. du Preez, I. Havlík, & Douglas W. Oliver. (2001). Discrimination between the functional and biochemical effects of two herbal oxytocics on the rat myometrium. Journal of Pharmacy and Pharmacology. 53(8). 1145–1151. 1 indexed citations
5.
6.
Veale, D.J.H., Douglas W. Oliver, & I. Havlík. (2000). The effects of herbal oxytocics on the isolated “stripped” myometrium model. Life Sciences. 67(11). 1381–1388. 12 indexed citations
7.
Stillings, Michael R., et al.. (2000). Comparison of the Pharmacokinetic Profiles of Soluble Aspirin and Solid Paracetamol Tablets in Fed and Fasted Volunteers. Current Medical Research and Opinion. 16(2). 115–124. 20 indexed citations
8.
Veale, D.J.H., et al.. (1999). Pharmacological effects of Agapanthus africanus on the isolated rat uterus. Journal of Ethnopharmacology. 66(3). 257–262. 30 indexed citations
9.
Morrison, Dempsie B., et al.. (1998). The effect of curdlan sulphate on development in vitro of Plasmodium falciparum. Transactions of the Royal Society of Tropical Medicine and Hygiene. 92(1). 87–89. 37 indexed citations
10.
Veale, D.J.H., et al.. (1997). Preliminary screening of plants used in South Africa as traditional herbal remedies during pregnancy and labour. Journal of Ethnopharmacology. 55(3). 185–191. 71 indexed citations
11.
Havlík, I., et al.. (1996). Effect of pH on in Vitro Potency of Amantadine Against Plasmodium falciparum. American Journal of Tropical Medicine and Hygiene. 54(3). 232–236. 5 indexed citations
12.
Havlík, I., et al.. (1994). In vitro drug interaction between amantadine and classical antimalarial drugs in Plasmodium falciparum infections. Transactions of the Royal Society of Tropical Medicine and Hygiene. 88(6). 683–686. 7 indexed citations
13.
Havlík, I., et al.. (1994). The effect of curdlan sulphate on in vitro growth of Plasmodium falciparum. Transactions of the Royal Society of Tropical Medicine and Hygiene. 88(6). 686–687. 21 indexed citations
14.
15.
Zyl, Robyn L. van, et al.. (1993). Malaria pigment and extracellular iron. Biochemical Pharmacology. 45(7). 1431–1436. 13 indexed citations
16.
Zyl, Robyn L. van, et al.. (1992). The combined effect of iron chelators and classical antimalarials on the in-vitro growth of Plasmodium falciparum. Journal of Antimicrobial Chemotherapy. 30(3). 273–278. 18 indexed citations
17.
Marik, Paul E., et al.. (1991). The pharmacokinetics of amikacin in critically ill adult and paediatric patients: comparison of once- versus twice-daily dosing regimens. Journal of Antimicrobial Chemotherapy. 27(suppl C). 81–89. 69 indexed citations
18.
Havlík, I., et al.. (1991). Possible mechanism of action of desferrioxamine and 2,2′-bipyridyl on inhibiting the in vitro growth of Plasmodium falciparum (FCR 3 strain). Biochemical Pharmacology. 42(8). 1633–1634. 5 indexed citations
19.
Havlík, I., et al.. (1990). Malaria at Johannesburg Hospital. A retrospective study.. PubMed. 78(8). 467–9. 2 indexed citations
20.
Mašek, K., et al.. (1973). Lipid-Induced Changes of Pentobarbital Distribution and Metabolism. Pharmacology. 10(3). 152–160. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean-Jacques Dugoua Breakdown of academic impact, for papers by Jill M. Grimes Serrano Breakdown of academic impact, for papers by Ananya Chatterjee Breakdown of academic impact, for papers by B. Diquet Breakdown of academic impact, for papers by J. K. Faulkner Breakdown of academic impact, for papers by Pingping Jiang Breakdown of academic impact, for papers by Douglas D. Glover Breakdown of academic impact, for papers by Indu Mani Breakdown of academic impact, for papers by Kathleen M. Job Breakdown of academic impact, for papers by Marc G. Sturgill
Rankless by CCL
2026